Oxidized Lipids Block Antigen Cross-Presentation by Dendritic Cells in Cancer

Wei Cao(Moffitt Cancer Center), Rupal Ramakrishnan(Moffitt Cancer Center), Vladimir A. Tuyrin(University of Pittsburgh), Filippo Veglia(The Wistar Institute), Thomas Condamine(The Wistar Institute), Andrew A. Amoscato(Moffitt Cancer Center), Dariush Mohammadyani(University of Pittsburgh), Joseph J. Johnson(Moffitt Cancer Center), Lan Min Zhang(Moffitt Cancer Center), Judith Klein‐Seetharaman(University of Warwick), Esteban Celis(Moffitt Cancer Center), Valerian E. Kagan(University of Pittsburgh), Dmitry I. Gabrilovich(The Wistar Institute)
The Journal of Immunology
February 20, 2014
Cited by 297Open Access
Full Text

Abstract

Cross-presentation is one of the main features of dendritic cells (DCs), which is critically important for the development of spontaneous and therapy-inducible antitumor immune responses. Patients, at early stages of cancer, have normal presence of DCs. However, the difficulties in the development of antitumor responses in patients with low tumor burden raised the question of the mechanisms of DC dysfunction. In this study, we found that, in differentiated DCs, tumor-derived factors blocked the cross-presentation of exogenous Ags without inhibiting the Ag presentation of endogenous protein or peptides. This effect was caused by intracellular accumulation of different types of oxidized neutral lipids: triglycerides, cholesterol esters, and fatty acids. In contrast, the accumulation of nonoxidized lipids did not affect cross-presentation. Oxidized lipids blocked cross-presentation by reducing the expression of peptide-MHC class I complexes on the cell surface. Thus, this study suggests the novel role of oxidized lipids in the regulation of cross-presentation.


Related Papers

No related papers found

Powered by citation graph analysis